Cargando…
Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450169/ https://www.ncbi.nlm.nih.gov/pubmed/28558755 http://dx.doi.org/10.1186/s12917-017-1065-9 |
_version_ | 1783239911079411712 |
---|---|
author | Hindenberg, Sarah Klenner-Gastreich, Stefanie Kneier, Nicole Zielinsky, Sabine Gommeren, Kris Bauer, Natali Moritz, Andreas |
author_facet | Hindenberg, Sarah Klenner-Gastreich, Stefanie Kneier, Nicole Zielinsky, Sabine Gommeren, Kris Bauer, Natali Moritz, Andreas |
author_sort | Hindenberg, Sarah |
collection | PubMed |
description | BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to independently evaluate the canine-specific CRP assay on the ABX Pentra 400 clinical chemistry analyzer in comparison to the previously validated human-based immunoturbidimetric assay (Randox Canine CRP assay) and 2) to assess the impact of different sample types (serum versus heparinized plasma) on the results. Imprecision, accuracy, interference and the prozone effect were determined using samples from healthy and diseased dogs (n = 278). The Randox Canine CRP assay calibrated with canine specific control calibration material served as a reference method. Additionally, the impact of the sample type (serum and lithium heparin) was evaluated based on samples of healthy and diseased dogs (n = 49) in a second part of the study. RESULTS: Linearity was present for CRP concentrations ranging from 4 to 281 mg/l. For clinically relevant CRP concentrations of 7–281 mg/l, recovery ranged between 90 and 105% and intra- and inter-assay CVs ranged between 0.68% - 12.12% and 0.88% - 7.84%, respectively. CV was thus lower than 12.16%, i.e. the desired CV% based on biological variation. Interference was not present up to a concentration of 5 g/l hemoglobin, 800 mg/l bilirubin and 10 g/l triglycerides. No prozone effect occurred up to 676 mg/l CRP. Method comparison study revealed a Spearman’s rank correlation coefficient of r(s) = 0.98 and a mean constant bias of 5.2%. The sample type had a significant (P = 0.008) but clinically not relevant impact on the results (median CRP of 30.9 mg/l in lithium heparin plasma versus 31.4 mg/l in serum). CONCLUSIONS: The species-specific Gentian Canine CRP Immunoassay reliably detects canine CRP on the ABX Pentra 400 clinical chemistry analyzer whereby both serum and heparin plasma can be used. The quality criteria reached on the Abbott Architect c4000 and Olympus AU600 could be met. |
format | Online Article Text |
id | pubmed-5450169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54501692017-06-01 Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer Hindenberg, Sarah Klenner-Gastreich, Stefanie Kneier, Nicole Zielinsky, Sabine Gommeren, Kris Bauer, Natali Moritz, Andreas BMC Vet Res Research Article BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to independently evaluate the canine-specific CRP assay on the ABX Pentra 400 clinical chemistry analyzer in comparison to the previously validated human-based immunoturbidimetric assay (Randox Canine CRP assay) and 2) to assess the impact of different sample types (serum versus heparinized plasma) on the results. Imprecision, accuracy, interference and the prozone effect were determined using samples from healthy and diseased dogs (n = 278). The Randox Canine CRP assay calibrated with canine specific control calibration material served as a reference method. Additionally, the impact of the sample type (serum and lithium heparin) was evaluated based on samples of healthy and diseased dogs (n = 49) in a second part of the study. RESULTS: Linearity was present for CRP concentrations ranging from 4 to 281 mg/l. For clinically relevant CRP concentrations of 7–281 mg/l, recovery ranged between 90 and 105% and intra- and inter-assay CVs ranged between 0.68% - 12.12% and 0.88% - 7.84%, respectively. CV was thus lower than 12.16%, i.e. the desired CV% based on biological variation. Interference was not present up to a concentration of 5 g/l hemoglobin, 800 mg/l bilirubin and 10 g/l triglycerides. No prozone effect occurred up to 676 mg/l CRP. Method comparison study revealed a Spearman’s rank correlation coefficient of r(s) = 0.98 and a mean constant bias of 5.2%. The sample type had a significant (P = 0.008) but clinically not relevant impact on the results (median CRP of 30.9 mg/l in lithium heparin plasma versus 31.4 mg/l in serum). CONCLUSIONS: The species-specific Gentian Canine CRP Immunoassay reliably detects canine CRP on the ABX Pentra 400 clinical chemistry analyzer whereby both serum and heparin plasma can be used. The quality criteria reached on the Abbott Architect c4000 and Olympus AU600 could be met. BioMed Central 2017-05-30 /pmc/articles/PMC5450169/ /pubmed/28558755 http://dx.doi.org/10.1186/s12917-017-1065-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hindenberg, Sarah Klenner-Gastreich, Stefanie Kneier, Nicole Zielinsky, Sabine Gommeren, Kris Bauer, Natali Moritz, Andreas Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title | Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title_full | Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title_fullStr | Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title_full_unstemmed | Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title_short | Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer |
title_sort | evaluation of a species-specific c-reactive protein assay for the dog on the abx pentra 400 clinical chemistry analyzer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450169/ https://www.ncbi.nlm.nih.gov/pubmed/28558755 http://dx.doi.org/10.1186/s12917-017-1065-9 |
work_keys_str_mv | AT hindenbergsarah evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT klennergastreichstefanie evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT kneiernicole evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT zielinskysabine evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT gommerenkris evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT bauernatali evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer AT moritzandreas evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer |